Office of the Chief Medical Officer expert Q&As
The company’s mission is to care for the world—one person at a time. Just ask Chief Medical Officer Joanne Waldstreicher, M.D., who’s been leading the charge to improve the process by which very sick patients may apply for access to investigational medications.
A Q&A with Gary Eichenbaum, Ph.D., Vice President, Translational Science and Safety, Office of the Chief Medical Officer, Johnson & Johnson
We asked Aran Maree, M.D., Chief Medical Officer for Janssen Pharmaceuticals, to give us the scoop on what to do with out-of-date drugs.
A Q&A with Jesse Berlin, Sc.D., Vice President and Global Head of Epidemiology, Johnson & Johnson, about why open access in scientific publishing is important and how Johnson & Johnson is helping pave the way forward.
Stopping pandemics before they strike: What you need to know about the Coalition for Epidemic Preparedness Innovations
Johnson & Johnson’s Chief Medical Officer for Global Public Health had a front row seat at the World Economic Forum this year as part of a new coalition aimed at helping to advance vaccine development for pathogens.
How our scientific and evidence-based approach to real-world evidence helps define patient and consumer outcomes
Health care companies develop innovative new medicines and products to meet patient needs and improve lives. Once devices and medicines are in use, our group evaluates how they perform in a real-world setting, looking at patient outcomes as well as the impact on cost of care.
Advancing Human Health and Innovation Excellence: Spotlight on Johnson & Johnson’s Bioethics Efforts
A Q&A with Ed Kuffner, M.D., Chief Medical Officer, Johnson & Johnson Consumer Inc.
The OCMO takes an evidence- and science-based, ethics- and values-driven approach to medical safety—with an emphasis on transparency. This has led to the development of policies and initiatives that keep the needs of patients and consumers at the center of our efforts.